Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Herentals – page 168

2 092 clinical trials in Herentals, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Herentals at a glance
2 092
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 092 trials in Herentals

Open in trial search

Study on the Effects of Adalimumab and Saline in Patients Undergoing Needle Fasciotomy for Dupuytren's Disease

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:UZ Leuven

Cardiac failure+1

Not recruiting

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:AZD3427
  • Sponsor:AstraZeneca AB

Ischaemic stroke

Not recruiting

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Insel Gruppe AG

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Onzemipgene parvec
  • Sponsor:Janssen Cilag International

Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Volixibat
  • Sponsor:Mirum Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-668
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Open angle glaucoma+2

Not recruiting

Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Citicoline Sodium
  • Sponsor:Omikron Italia S.r.l.

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Malignant melanoma

Not recruiting

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Factor VIII deficiency+3

Not recruiting

Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Sponsor:Apcintex Limited

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

Investigational
Countries:BelgiumBelgium
  • Participants:65+ years
  • Substances:Xevinapant
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Herentals

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on follicular lymphoma and diffuse large B-cell lymphoma, evaluating novel therapeutic approaches against traditional treatments.

  • Comparative treatment studies
  • Safety and efficacy evaluation
  • Advanced lymphoma therapies

These trials aim to improve treatment outcomes for patients with various forms of lymphoma through targeted therapies.

02 Multiple Myeloma Research

Groundbreaking studies exploring early intervention in monoclonal gammopathy and smoldering multiple myeloma conditions.

  • Plasma cell disorders
  • Early disease intervention
  • Novel therapeutic approaches

Research focused on preventing progression to active multiple myeloma through innovative treatments.

03 Rheumatology Studies

Investigation of treatment strategies for rheumatoid arthritis, comparing conventional approaches with accelerated biological therapy access.

  • Early RA intervention
  • Long-term effectiveness
  • Treatment optimization

Comprehensive evaluation of various treatment approaches for better disease management outcomes.

04 Gastroenterology Research

Studies examining optimal approaches for PPI deprescription in patients with various gastrointestinal conditions including functional dyspepsia and reflux.

  • Medication optimization
  • Alternative treatment strategies
  • Patient-centered approaches

Focused on developing effective strategies for reducing long-term PPI use while maintaining symptom control.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.